政府:復必泰現包裝瑕疵或由運輸環境引致 無證據顯示疫苗存安全風險
政府公布,早前衛生署發現復必泰疫苗累計多宗包裝瑕疵,已即時通報疫苗供應商並要求立刻跟進,根據復星及BioNTech到目前為止所完成的調查,並未發現疫苗由封裝到使用的過程中,有任何可能造成相關包裝瑕疵的顯著系統性因素。現階段調查結果不排除有關情況是由長途運輸過程中環境因素所引致。然而綜合調查所得數據,相信出現有關情況並非與冷鏈及物流管理有關。至於其餘已抵港的疫苗,經隨機抽樣測試包裝完整的疫苗藥瓶,亦並未發現疫苗滲漏的問題。
根據初步調查結果,復星與德國藥廠BioNTech認為沒有證據顯示已抵港的復必泰疫苗存在安全風險,已接種復必泰疫苗的市民無需擔心,後續調查工作主要以查證相關疫苗批次並無任何固有特性問題而可繼續安全使用為目標。
政府正與復星和德國藥廠BioNTech積極跟進,爭取在一周內完成調查程序,並會與供應商就餘下疫苗供應保持密切聯繫,確保本港疫苗接種計劃能夠持續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.